Working… Menu
Trial record 1 of 1 for:    NCT03478488
Previous Study | Return to List | Next Study

Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC (KN035-BTC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03478488
Recruitment Status : Recruiting
First Posted : March 27, 2018
Last Update Posted : March 23, 2021
Information provided by (Responsible Party):
3D Medicines ( 3D Medicines (Sichuan) Co., Ltd. )

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : June 30, 2022